Stay updated on Pembrolizumab Post-Surgery in MSI-H Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Post-Surgery in MSI-H Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Post-Surgery in MSI-H Solid Tumors Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.
    Difference
    0.1%
    Check dated 2025-05-01T05:37:32.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    The webpage has been updated to reflect a new version of a clinical study on adjuvant pembrolizumab for patients with MSI-H solid tumors, including changes in the study's description and the principal investigator's name.
    Difference
    42%
    Check dated 2025-04-16T14:41:17.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The web page has updated its version from v2.14.3 to v2.14.4, and the date has changed from March 25, 2025, to March 4, 2025.
    Difference
    0.2%
    Check dated 2025-04-09T09:47:18.000Z thumbnail image
  6. Check
    59 days ago
    Change Detected
    Summary
    The webpage has updated its date references, removing several past dates and adding future dates, indicating a shift in the timeline of events or updates.
    Difference
    1.0%
    Check dated 2025-03-11T04:39:15.000Z thumbnail image
  7. Check
    73 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    1%
    Check dated 2025-02-24T21:10:56.000Z thumbnail image
  8. Check
    87 days ago
    Change Detected
    Summary
    The web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.
    Difference
    1%
    Check dated 2025-02-10T10:17:42.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Post-Surgery in MSI-H Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Post-Surgery in MSI-H Solid Tumors Clinical Trial page.